Sun H Kim1, Gerald Reaven. 1. MD, MS, Stanford University Medical Center, 300 Pasteur Drive, Room S025, Stanford, California 94305-5103. sunhkim@stanford.edu.
Abstract
CONTEXT: The possibility that differences in insulin sensitivity explain why women, especially younger women, have a lower cardiovascular disease (CVD) risk than men remains an unsettled issue. OBJECTIVE: The objective of this study was to evaluate whether sex disparities in CVD risk are associated with differences in insulin resistance. DESIGN/SETTING/PARTICIPANTS: This was a cross-sectional study of women (n = 468) and men (n = 354) who had the measurement of CVD risk factors and steady-state plasma glucose (SSPG) concentration (insulin resistance) using the insulin suppression test. The population was also divided by median age (51 y) to evaluate the effect of age on sex differences. MAIN OUTCOME MEASURES/ RESULTS: In general, the SSPG concentration was similar between sexes. At higher BMI (≥30 kg/m(2)), women had significantly lower SSPG concentration than men (sex × BMI interaction, P = .001). However, sex differences in CVD risk factors were not due to differences in SSPG but accentuated by a higher degree of insulin resistance in younger (age < 51 y) but not older (≥ 51 y) individuals. In younger individuals, women had significantly (P ≤ .007) lower diastolic blood pressure and fasting glucose and triglyceride concentration compared with men in SSPG tertile 3 (most insulin resistant) but not in tertile 1 (least insulin resistant). Older women had lower diastolic blood pressure compared with men, regardless of SSPG. High-density lipoprotein cholesterol remained higher in women, regardless of age or SSPG. CONCLUSIONS: The female advantage is not due to a difference in insulin action but results from an attenuation of the relationship between insulin resistance and CVD risk, especially in younger individuals.
CONTEXT: The possibility that differences in insulin sensitivity explain why women, especially younger women, have a lower cardiovascular disease (CVD) risk than men remains an unsettled issue. OBJECTIVE: The objective of this study was to evaluate whether sex disparities in CVD risk are associated with differences in insulin resistance. DESIGN/SETTING/PARTICIPANTS: This was a cross-sectional study of women (n = 468) and men (n = 354) who had the measurement of CVD risk factors and steady-state plasma glucose (SSPG) concentration (insulin resistance) using the insulin suppression test. The population was also divided by median age (51 y) to evaluate the effect of age on sex differences. MAIN OUTCOME MEASURES/ RESULTS: In general, the SSPG concentration was similar between sexes. At higher BMI (≥30 kg/m(2)), women had significantly lower SSPG concentration than men (sex × BMI interaction, P = .001). However, sex differences in CVD risk factors were not due to differences in SSPG but accentuated by a higher degree of insulin resistance in younger (age < 51 y) but not older (≥ 51 y) individuals. In younger individuals, women had significantly (P ≤ .007) lower diastolic blood pressure and fasting glucose and triglyceride concentration compared with men in SSPG tertile 3 (most insulin resistant) but not in tertile 1 (least insulin resistant). Older women had lower diastolic blood pressure compared with men, regardless of SSPG. High-density lipoprotein cholesterol remained higher in women, regardless of age or SSPG. CONCLUSIONS: The female advantage is not due to a difference in insulin action but results from an attenuation of the relationship between insulin resistance and CVD risk, especially in younger individuals.
Authors: J O Clausen; K Borch-Johnsen; H Ibsen; R N Bergman; P Hougaard; K Winther; O Pedersen Journal: J Clin Invest Date: 1996-09-01 Impact factor: 14.808
Authors: Joshua W Knowles; Themistocles L Assimes; Philip S Tsao; Andrea Natali; Andrea Mari; Thomas Quertermous; Gerald M Reaven; Fahim Abbasi Journal: Metabolism Date: 2012-11-12 Impact factor: 8.694
Authors: Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef Journal: J Clin Endocrinol Metab Date: 2012-09 Impact factor: 5.958
Authors: Simon Verhulst; Christine Dalgård; Carlos Labat; Jeremy D Kark; Masayuki Kimura; Kaare Christensen; Simon Toupance; Abraham Aviv; Kirsten O Kyvik; Athanase Benetos Journal: Diabetologia Date: 2016-03-28 Impact factor: 10.122
Authors: Nasser M Al-Daghri; Yousef Al-Saleh; Naji Aljohani; Majed Alokail; Omar Al-Attas; Abdullah M Alnaami; Shaun Sabico; Maha Alsulaimani; Mohammed Al-Harbi; Hanan Alfawaz; George P Chrousos Journal: PLoS One Date: 2015-07-17 Impact factor: 3.240